Results 71 to 80 of about 4,727 (145)

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

open access: yesPulmonary Circulation, 2019
Diagnostic World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) and Diagnostic Group 1' pulmonary veno-occlusive disease (PVOD) and/or pulmonary capillary hemangiomatosis (PCH) are progressive and fatal disorders. Past registries
C. Gregory Elliott   +13 more
doaj   +1 more source

Heritable pulmonary hypertension: from bench to bedside

open access: yesEuropean Respiratory Review, 2017
Mutations in the BMPR2 gene, and more rarely in ACVRL1, endoglin, caveolin-1, KCNK3 and TBX4 genes predispose to heritable pulmonary arterial hypertension, an autosomal dominant disease with incomplete penetrance. Bi-allelic mutations in the EIF2AK4 gene
Barbara Girerd   +3 more
doaj   +1 more source

Comprehensive three‐dimensional morphology of neoangiogenesis in pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis

open access: yesThe Journal of Pathology: Clinical Research, 2019
Pulmonary veno‐occlusive disease (PVOD) is a rare lung disease characterized by fibrotic narrowing of pulmonary veins leading to pulmonary hypertension (PH) and finally to death by right heart failure.
Lavinia Neubert   +12 more
doaj   +1 more source

Pulmonary Veno-Occlusive Disease

open access: yesAdvances in Pulmonary Hypertension, 2023
Salma Al Kahf   +3 more
openaire   +1 more source

Case report: A finding of PVOD and PAH in first degree relatives suggests shared heritable risk and overlapping features of both pulmonary vascular diseases

open access: yesRespirology Case Reports
Pulmonary veno‐occlusive disease (PVOD) is a rare form of pulmonary vascular disease that is difficult to distinguish clinically from pulmonary arterial hypertension (PAH).
Roger Winters   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy